Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nesdonal versus etomidate combination sedation for cataract surgery
IRCT20230715058780N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of thiopental, etomidate, fentanyl and midazolam in cataract (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Complications frequency and Complications severity. Started Aug 2023; status: completed.
02
Drugs
thiopentaletomidatefentanylmidazolam
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20230715058780N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230715058780N1.